Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes-Reference-Cited by-同舟云学术

Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes

Published:2009-08 Issue:8 Volume:19 Page:613-625
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Bradbury Penelope A.,Kulke Matthew H.,Heist Rebecca S.,Zhou Wei,Ma Clement,Xu Wei,Marshall Ariela L.,Zhai Rihong,Hooshmand Susanne M.,Asomaning Kofi,Su Li,Shepherd Frances A.,Lynch Thomas J.,Wain John C.,Christiani David C.,Liu Geoffrey

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference37 articles.

1. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males;Bollschweiler;Cancer,2001

2. Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial;Brucher;Eur J Surg Oncol,2004

3. Esophageal cancer;Enzinger;N Engl J Med,2003

4. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis;Greer;Surgery,2005

5. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma;Walsh;N Engl J Med,1996

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Red‐Light‐Responsive Metallopolymer Nanocarriers with Conjugated and Encapsulated Drugs for Phototherapy Against Multidrug‐Resistant Tumors;Small;2022-06-03

2. The Ability of Polymorphisms in DNA Repair Enzymes to Predict Clinical Outcome in Colorectal Cancer Patients;MIDDLE EAST J CANCER;2020

3. The circadian clock gene Bmal1 facilitates cisplatin-induced renal injury and hepatization;Cell Death & Disease;2020-06

4. Identification of host variants associated with overall survival of esophageal cancer patients receiving platinum-based therapy;Pharmacogenomics;2020-04

5. Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer;Frontiers in Oncology;2019-02-21